Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /4117
chevron_leftBack
General Biologicals Corp. logo

General Biologicals Corp.

4117
TPEX: 4117 Delayed
4.15TWD 0%
0.1313 USD
As of 6 June 2026, General Biologicals Corp. has a market cap of $8.02M USD, ranking #42408 globally and #2335 in Taiwan. It ranks #3754 in the Healthcare sector, and #261 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
42408
Country Rank
2335
Sector Rank
3754
Industry Rank
261
Key Stats
Market Cap
$8.02MUSD
252.42M TWD
Enterprise Value
$81.38MUSD
2.57B TWD
Revenue (TTM)
$7.99MUSD
251.38M TWD
EBITDA (TTM)
-$5.79MUSD
-182.84M TWD
Net Income (TTM)
-$7.74MUSD
-243.6M TWD
EBITDA Margin
-73%
Profit Margin
-97%
PS Ratio
1.0
PB Ratio
1.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Frank Lin open_in_new
Employees
81
Founded
1984
Website
gbc.com.tw open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -64% -66% -68% -74% -78%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
4117
普生股份有限公司
ISIN: TW0004117007
Shares Out.:
70.824M1
TV:
SA:
YF:
GF:
BA:
MS:
4.15 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About General Biologicals Corp.

General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally. It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services. The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma. Additionally, it offers a range of oral care products under the oh care brand. Further, the company serves its diagnostic solutions through clinics and laboratories. General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)
Name
Market Cap diff.
PE
$1.68B
52.95B TWD
21K%
17.9
1707
$536.85M
16.89B TWD
7K%
14.0
$476.38M
14.99B TWD
6K%
36.5
8436
$415.07M
13.06B TWD
5K%
13.7
4128
$291.68M
9.18B TWD
4K%
-
7832
$244.3M
7.69B TWD
3K%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
469K%
24.2
$29.56B
368K%
-
$15.86B
107.34B CNY
197K%
16.0
CIPLA
$11.12B
1.06T INR
138K%
23.4
LUPIN
$11.0B
1.05T INR
137K%
22.7
$9.1B
61.6B CNY
113K%
80.6
chevron_leftBack